So here's how things will play out - stock price with trend in the high 2's (thanks to the shorts) for a few more days, and then a financing PR will be announced sending the stock above $3, and then within a day or two thereafter another PR will announce a filing with NYSE American for uplisting, and then within a week thereafter Cytodyn will start trading on NYSE American, and then within a week thereafter NP will submit clinical trial data to FDA/the world, and then within two weeks thereafter FDA approval of Leronlimab for covid. All of this by June 30. Imho of course.